JULY 14, 2022 UPDATE:
WASHINGTON (AP) — U.S. officials say thousands more doses of the monkeypox vaccine could soon begin shipping from Denmark. The Food and Drug Administration says it has completed a required inspection of the overseas plant where the two-dose shots are manufactured. The update comes amid soaring demand for the shots in New York City, California and other parts of the U.S. The U.S. government purchased more than 1.1 million doses of the vaccine from Bavarian Nordic, most which are still in storage at the company’s Denmark plant. But the FDA requires an on-site inspection before vaccines from a new plant can be cleared. An FDA spokesperson said its inspection was recently completed.
JULY 14, 2022:
NEW YORK (AP) — Soaring demand for the monkeypox vaccine caused the appointment system to crash in New York City, one of many places where supplies have been running out almost as soon as they arrive. City health officials acknowledged the frustration over the limited supply of the vaccine and vowed to build a “stable appointment infrastructure” as the vaccine supply increases. Infections now exceed 1,000 from the growing outbreak in the U.S. Most patients experience only fever, body aches, chills and fatigue. People with more serious illness may develop a rash and lesions on the face and hands that can spread to other parts of the body.